HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer

  • Nadia Harbeck, Matthias W. Beckmann, Achim Rody, Andreas Schneeweiss, Volkmar Müller, Tanja Fehm, Norbert Marschner, Oleg Gluz, Iris Schrader, Georg Heinrich, Michael Untch, Christian Jackisch
  • Breast Care, January 2013, Karger Publishers
  • DOI: 10.1159/000346837

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Norbert W Marschner